咳止め・風邪薬の世界市場の機会と2032年までの戦略Including：1) 薬剤タイプ別薬剤タイプ別：抗ヒスタミン薬、去痰薬、気管支拡張薬、鬱血除去薬、抗生物質2）用量タイプ別：経口シロップ、錠剤/丸薬、点鼻薬、トローチ3）2032年までの世界市場機会と戦略：経口シロップ; 錠剤/丸薬; 点鼻薬; ロゼンジ3) 販売チャネル別：病院薬局; 小売薬局; ドラッグストアCovering：ジョンソン・エンド・ジョンソン；グラクソ・スミスクライン；プロクター・アンド・ギャンブル；バイエル；レキットベンキーザーグループ

Cough And Cold Preparations Global Market Opportunities And Strategies To 2032Including: 1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug StoresCovering: Johnson & Johnson; GlaxoSmithKline plc; Procter & Gamble; Bayer AG; Reckitt Benckiser Group plc

この調査レポートは、咳と風邪薬の世界市場の2032年までのビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。購入の理由 - 12地域をカバーするこの市場に関する最も包括... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年2月20日	US$5,000 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	317	英語

サマリー

この調査レポートは、咳と風邪薬の世界市場の2032年までのビジネスチャンスと戦略について調査・分析した結果を掲載したビジネス調査報告書です。

購入の理由
- 12地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がコロナウイルスによってどのような影響を受けているのか、また、ウイルスの影響が和らぐにつれて市場がどのように浮上し、成長していく可能性があるのかを理解することができます。
- 現地のデータと分析に基づき、地域別および国別の戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成するドライバーとトレンドを活用し、競合他社を凌駕する。
- 最新の市場調査結果に基づいて顧客を理解する。
- 主要な競合他社とのパフォーマンスの比較
- 主要データセット間の関係を活用し、優れた戦略を立てる。
- 信頼性の高い高品質なデータと分析により、社内外のプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、ご注文から3～5営業日以内にお届けします。

説明
咳止め・風邪薬の最大市場および急成長市場はどこか？同市場は経済全体、人口動態、その他の類似市場とどのような関係にあるのか？今後の市場を形成する勢力は何か？ビジネスリサーチ社の咳止め・風邪薬世界市場レポートでは、これらすべての疑問やその他多くの疑問にお答えします。
当レポートでは、市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、市場の動向と戦略を網羅しています。市場の歴史をたどり、地域別の市場成長を予測しています。咳止め・風邪薬市場全体の中で同市場を位置づけ、他市場との比較も行っています。

本レポートは以下の章をカバーしています。
- 序論と市場の特徴
咳・風邪薬市場に関する定義や解説、市場区分の簡単な紹介
- 主要動向
世界の咳止め・風邪薬市場を形成している主要トレンドをハイライトしています。また、同市場における今後の展開についても取り上げます。
- 世界の市場規模と成長
世界の過去（2017年～2022年）、予測（2022年～2027年）、（2027年～2032年）市場価値、過去および予測期間における市場の成長を支え、制御する促進要因と抑制要因。
- 地域別分析
地域別の過去（2017-2022年）および予測（2022-2027年）、（2027-2032年）市場価値と成長率、市場シェア比較。
- 市場セグメンテーション
市場におけるタイプ別、投与量タイプ別、流通チャネル別のセグメント別市場価値（2017-2032年）と分析を収録。
- 地域別市場規模と成長
地域別の市場規模（2022年）、過去（2017年～2022年）および予測（2022年～2027年）、（2027年～2032年）の市場価値、地域内各国の成長および市場シェア比較を掲載。本レポートには、アジア太平洋、西欧、東欧、北米、南米、中東、アフリカの全地域と各地域内の主要国に関する情報が含まれています。
- 競争環境
市場の競争状況、推定市場占有率、主要企業の会社プロファイルの詳細を掲載しています。
- 主要なM&A
本レポートでカバーしている市場における最近のM&Aに関する情報を掲載しています。本セクションでは、近年の市場を形成したM&Aに関する主要な財務情報を掲載しています。
- 市場機会と戦略
調査結果に基づく市場機会と戦略について、国やセグメントごとの成長機会や、それらの市場で取るべき戦略に関する情報を交えて記述しています。
- 結論と提言
製品・サービスの提供地域拡大、マーケティング戦略、ターゲット層など、咳・風邪薬メーカーへの提言が含まれています。
- 付録
本レポートで使用しているNAICSコード、略語、通貨コードの詳細を記載しています。

対象範囲
対象市場
1) 薬剤タイプ別薬剤タイプ別：抗ヒスタミン薬；去痰薬；気管支拡張薬；鬱血除去薬；抗生物質；その他の薬剤タイプ
2) 投与量タイプ別：経口シロップ；錠剤／丸薬；点鼻薬；トローチ；その他の剤型
3) 販売チャネル別病院薬局；小売薬局；ドラッグストア；その他の流通チャネル

言及された企業ジョンソン・エンド・ジョンソン；グラクソ・スミスクライン；プロクター・アンド・ギャンブル；バイエル；レキットベンキーザーグループ

国中国、オーストラリア、インド、インドネシア、日本、韓国、米国、ブラジル、フランス、ドイツ、英国、ロシア

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データデータ：市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、咳・風邪薬指標の比較。

データ区分：国別および地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

当レポートでは、咳止め・風邪薬市場について解説し、2017年から2022年までを過去期間、2022年から2027年までを予測期間とし、さらに2027年から2032年までの予測も掲載しています。各地域および各地域内の主要経済圏の市場を評価しています。

風邪薬・咳止め薬市場は、2017年以降年平均成長率（CAGR）8.6%で成長し、2022年には約667億5,420万ドルの規模に達した。同市場は、2022年の667億5,420万ドルから2027年には4.7%の成長率で840億2,190万ドルまで拡大すると予測される。その後、2027年から年平均成長率（CAGR）4.2%で成長し、2032年には1,033億8,450万ドルに達すると予想される。

歴史的期間の成長は、呼吸器系疾患の有病率の増加、タバコ喫煙の発生率の増加、地球温暖化、新興市場の力強い経済成長、医療支出の増加によってもたらされた。過去期間の成長にマイナスの影響を与えた要因は、特許の失効と政治的不確実性であった。

今後は、電子タバコ/ベイプの人気の高まり、肥満レベルの上昇、未診断人口の大規模なプール、政府の取り組みが成長を促進するだろう。今後の風邪薬・咳止め薬市場の成長を阻害する要因としては、呼吸器系薬剤に伴う副作用、自由貿易の縮小、ロシア・ウクライナ戦争の影響などが挙げられる。

風邪薬・咳止め薬市場は、薬剤タイプ別に抗ヒスタミン薬、去痰薬、気管支拡張薬、鬱血除去薬、抗生物質、その他の薬剤タイプに区分される。気管支拡張剤市場は、薬剤タイプ別にみた風邪薬・咳止め薬市場の中で最大のセグメントであり、2022年には全体の30.1%を占める。今後、去痰薬セグメントは、薬剤タイプ別に区分した風邪薬・咳止め薬市場において最も急速に成長するセグメントであり、2022〜2027年のCAGRは5.1%と予想される。

風邪薬・咳止め薬市場は、剤型別では経口シロップ、錠剤／ピル、点鼻薬、トローチ、その他の剤型に区分される。錠剤/ピル市場は、剤型別にみた風邪薬・咳止め薬市場において最大のセグメントであり、2022年には全体の45.0%を占めた。今後、錠剤/丸薬市場は、2022～2027年のCAGR 5.1%で、剤形別に区分した風邪薬・咳止め薬市場において最も急成長する分野となる見込みである。

風邪薬・咳止め薬市場は、流通チャネル別に病院薬局、小売薬局・ドラッグストア、その他の流通チャネルに区分される。小売薬局・薬店市場は、流通チャネル別にみた風邪薬・咳止め薬市場の最大セグメントであり、2022年には全体の57.4%を占めた。今後、その他の流通チャネル市場は、2022～2027年のCAGR 4.9%で、流通チャネル別に区分した風邪薬・咳止め薬市場において最も急成長するセグメントとなる見込みである。

北米は風邪薬・咳止め薬市場において最大の地域であり、2022年には全体の38.8%を占めた。次いでアジア太平洋地域、西ヨーロッパ地域、その他の地域と続く。今後、風邪薬・咳止め薬市場で最も急速に成長する地域はアジア太平洋地域と北米で、年平均成長率はそれぞれ5.3%と4.8%である。次いで西欧と東欧で、それぞれCAGR4.4％と3.9％の成長が見込まれる。

世界の咳止め・風邪薬市場は断片化されており、多数の小規模企業が存在する。同市場における上位10社の競合他社は、2021年には市場全体の11.15%を占めている。最近の技術革新が各社の市場プレゼンス強化に貢献した。最大の競合企業はジョンソン・エンド・ジョンソンで市場シェア2.29%、次いでグラクソ・スミスクラインplcが2.08%、プロクター・アンド・ギャンブルが1.75%、バイエルAGが1.62%、レキットベンキーザー・グループplcが1.33%、ノバルティスAGが1.09%、ペリゴ・カンパニーが0.46%、サン・ファーマシューティカル・インダストリーズ・リミテッドが0.28%、プレステージ・コンシューマー・ヘルスケアが0.17%、ブラックモア・リミテッドが0.08%となっている。

薬剤の種類別に区分した風邪薬・咳止め薬市場における最大のビジネスチャンスは気管支拡張薬セグメントにあり、2027年までに世界の年間売上高52億2,300万ドルを獲得する。用法・用量別に区分した風邪薬・咳止め薬市場における最大のビジネスチャンスは錠剤／ピルセグメントで、2027年までに世界の年間売上高で84億3,590万ドルに達するだろう。流通チャネル別にみた風邪薬・咳止め薬市場における最大のビジネスチャンスは、小売薬局・ドラッグストアで、2027年までに101億5,370万ドルの世界年間売上高を獲得すると予測される。風邪薬・咳止め薬の市場規模が最も拡大するのは米国で、68億1,020万ドルである。

風邪薬・咳止め薬市場の市場トレンドに基づく戦略としては、喘息治療へのプロバイオティクスの使用、先進気管支拡張薬の発売、新製品の発売、市場での合併・提携、個別化医薬品の需要の増加、エアゾール式呼吸器治療薬の需要、ジェネリック呼吸器治療薬の台頭、COPD治療のための薬物併用療法などが挙げられる。

風邪薬・咳止め薬市場における各社の戦略には、戦略的買収による事業能力の拡大、新製品の発売による事業運営と製品ポートフォリオの強化が含まれる。

ビジネス・リサーチ・カンパニーは、この機会を活用するため、風邪薬・咳止め薬メーカー各社に対し、新製品の上市に注力すること、個別化医薬品に注力すること、COPD治療のための併用薬物療法に注力すること、先進国市場に引き続き注力すること、戦略的提携や買収に注力すること、競争力のある価格設定に注力すること、医薬品セミナーや学会に参加すること、病院や薬局をターゲットに認知度を高めることを推奨している。

ページTOPに戻る

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Cough And Cold Preparations Market Definition and Segmentations
6.4. Market Segmentation by Drug Type
6.4.1. Antihistamines
6.4.2. Expectorants
6.4.3. Bronchodilators
6.4.4. Decongestants
6.4.5. Antibiotics
6.4.6. Other Drug Type
6.5. Market Segmentation by Dosage Type
6.5.1. Oral Syrups
6.5.2. Tablets/Pills
6.5.3. Nasal Drops
6.5.4. Lozenges
6.5.5. Other Dosage Types
6.6. Market Segmentation by Distribution Channel
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies And Drug Stores
6.6.3. Other Distribution Channels
7. Major Market Trends
7.1. Use Of Probiotics To Treat Asthma
7.2. Advanced Bronchodilators Launched
7.3. New Product Launches
7.4. Mergers And Collaborations In The Market
7.5. Increasing Demand For Personalized Medicines
7.6. Demand For Aerosol Respiratory Drugs
7.7. Rise Of Generic Respiratory Drugs
7.8. Combination Drug Therapy To Treat COPD
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Cough And Cold Preparations Market Segmentation
9.1. Global Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Cough And Cold Preparations Market, Regional and Country Analysis
10.1. Global Cough And Cold Preparations Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Cough And Cold Preparations Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Cough And Cold Preparations Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Major Associations
11.11.7. Taxes levied
11.11.8. Corporate tax structure
11.11.9. Investments
11.11.10. Major Companies
11.12. China Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Cough And Cold Preparations Market: Country Analysis
12.9. UK Market
12.10. UK Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Cough And Cold Preparations Market: Country Analysis
13.9. Russia Market
13.10. Russia Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Cough And Cold Preparations Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Region Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Government Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Cough And Cold Preparations Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Cough And Cold Preparations Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Cough And Cold Preparations Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Cough And Cold Preparations Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Cough And Cold Preparations Market, Segmentation By Dosage Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Cough And Cold Preparations Market, Segmentation By Distribution Channel, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. Johnson & Johnson
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. GlaxoSmithKline plc
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. The Procter & Gamble Company
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Bayer AG
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Financial Overview
18.6. Reckitt Benckiser Group plc
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Financial Overview
19. Key Mergers and Acquisitions
19.1. Olympus Corporation Acquired Veran Medical Technologies, Inc. (VMT)
19.2. Mankind Pharma Acquired Dr. Reddy's
19.3. Sandoz International GmbH Acquired Coalesce Product Development
19.4. Pfizer Acquired ReViral
19.5. AstraZeneca Gets US Clearance For Proposed Alexion Acquisition
19.6. ResMed Acquired Propeller Health
20. Opportunities And Strategies
20.1. Global Cough And Cold Preparations Market In 2027 – Countries Offering Most New Opportunities
20.2. Global Cough And Cold Preparations Market In 2027 – Segments Offering Most New Opportunities
20.3. Global Cough And Cold Preparations Market In 2027 – Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Cough And Cold Preparations Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. The Business Research Company
22.5. Copyright and Disclaimer

ページTOPに戻る

Table of Contents

Summary

Cough And Cold Preparations Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global cough and cold preparations market as it emerges from the COVID 19 shut down.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest-growing market for cough and cold preparations? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider cough and cold preparations market; and compares it with other markets.

The report covers the following chapters
• Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about cough and cold preparations market.
• Key Trends
Highlights the major trends shaping the global cough and cold preparations market. This section also highlights likely future developments in the market.
• Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
• Market Segmentation
Contains the market values (2017-2032) and analysis for segment by type, by dosage type and by distribution channel in the market.
• Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations
Includes recommendations for cough and cold preparations providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope
Markets Covered:
1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Other Drug Types.
2) By Dosage Type: Oral Syrups; Tablets/Pills; Nasal Drops; Lozenges; Other Dosage Types
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Other Distribution Channels.

Companies Mentioned: Johnson & Johnson; GlaxoSmithKline plc; Procter & Gamble; Bayer AG; Reckitt Benckiser Group plc

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; cough and cold preparations indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report describes and explains the cough and cold preparations market and covers 2017 to 2022, termed the historic period, and 2022 to 2027 termed the forecast period, along with further forecasts for the period 2027-2032. The report evaluates the market across each region and for the major economies within each region.

The cold and cough preparations market reached a value of nearly $66,754.2 million in 2022, having grown at a compound annual growth rate (CAGR) of 8.6% since 2017. The market is expected to grow from $66,754.2 million in 2022 to $84,021.9 million in 2027 at a rate of 4.7%. The market is then expected to grow at a CAGR of 4.2% from 2027 and reach $103,384.5 million in 2032.

Growth in the historic period resulted from increased prevalence of respiratory diseases, increased incidence of tobacco smoking, global warming, strong economic growth in emerging markets and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents and political uncertainties.

Going forward, increased popularity of e-cigarettes/ vaping, rising obesity levels, large pool of undiagnosed population and government initiatives will drive the growth. Factors that could hinder the growth of the cold and cough preparations market in the future include side effects associated with respiratory drugs, reduction in free trade and Russia-Ukraine war impact.

The cold and cough preparations market is segmented by drug type into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, other drug types. The bronchodilators market was the largest segment of the cold and cough preparations market segmented by drug type, accounting for 30.1% of the total in 2022. Going forward, the expectorants segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by drug type, at a CAGR of 5.1% during 2022-2027.

The cold and cough preparations market is segmented by dosage type into oral syrups, tablets/pills, nasal drops, lozenges and other dosage types. The tablets/pills market was the largest segment of the cold and cough preparations market segmented by dosage type, accounting for 45.0% of the total in 2022. Going forward, the tablets/pills segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by dosage type, at a CAGR of 5.1% during 2022-2027.

The cold and cough preparations market is segmented by distribution channel into hospital pharmacies, retail pharmacies and drug stores and other distribution channels. The retail pharmacies and drug stores market was the largest segment of the cold and cough preparations market segmented by distribution channel, accounting for 57.4% of the total in 2022. Going forward, the other distribution channels segment is expected to be the fastest growing segment in the cold and cough preparations market segmented by distribution channel, at a CAGR of 4.9% during 2022-2027.

North America was the largest region in the cold and cough preparations market, accounting for 38.8% of the total in 2022. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the cold and cough preparations market will be Asia Pacific and North America where growth will be at CAGRs of 5.3% and 4.8% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 4.4% and 3.9% respectively.

The Global cough and cold preparations market is fragmented, with a large number of small players. The top ten competitors in the market made up to 11.15% of the total market in 2021. Technological innovations in the recent past helped the companies to strengthen their market presence. Johnson & Johnson was the largest competitor with 2.29% share of the market, followed by GlaxoSmithKline plc with 2.08%, Procter & Gamble with 1.75%, Bayer AG with 1.62%, Reckitt Benckiser Group plc with 1.33%, Novartis AG with 1.09%, Perrigo Company with 0.46%, Sun Pharmaceutical Industries Ltd. with 0.28%, Prestige Consumer Healthcare with 0.17%, and Blackmores Limited with 0.08%.

The top opportunities in the cold and cough preparations market segmented by drug type will arise in the bronchodilators segment, which will gain $5,223.0 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by dosage type will arise in the tablets/pills segment, which will gain $8,435.9 million of global annual sales by 2027. The top opportunities in the cold and cough preparations market segmented by distribution channel will arise in the retail pharmacies and drug stores segment, which will gain $10,153.7 million of global annual sales by 2027. The cold and cough preparations market size will gain the most in USA at $6,810.2 million.

Market-trend-based strategies for the cold and cough preparations market include use of probiotics to treat asthma, advanced bronchodilators launched, new product launches, mergers and collaborations in the market, increasing demand for personalized medicines, demand for aerosol respiratory drugs, rise of generic respiratory drugs and combination drug therapy to treat COPD.

Player-adopted strategies in the cold and cough preparations market includes focus on expanding operational capabilities through strategic acquisitions, enhancing business operations and product portfolio through the launch of new products.

To take advantage of the opportunities, The Business Research Company recommends the cold and cough preparations companies to focus on new product launches, focus on personalized medicines, focus on combination drug therapy to treat COPD, continue to focus on developed markets, focus on strategic collaborations and acquisitions, focus on competitive pricing, participate in medicine seminars and conferences and target hospitals and pharmacies to spread awareness.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

The Business Research Company　(TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（antihistamines）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

The Business Research Company (TBRC) 社の最新刊レポート

本レポートと同じKEY WORD（antihistamines）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC) 社の最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?